Previous Close | 512.40 |
Open | 520.70 |
Bid | 518.40 x N/A |
Ask | 519.30 x N/A |
Day's Range | 509.30 - 522.30 |
52 Week Range | 426.20 - 595.60 |
Volume | |
Avg. Volume | 162 |
Market Cap | 204.855B |
Beta (5Y Monthly) | 0.83 |
PE Ratio (TTM) | 27.89 |
EPS (TTM) | 18.60 |
Earnings Date | Jul 26, 2022 - Aug 01, 2022 |
Forward Dividend & Yield | 1.15 (0.22%) |
Ex-Dividend Date | Jun 14, 2022 |
1y Target Est | N/A |
Life sciences company Thermo Fisher Scientific (NYSE: TMO) played an instrumental role in delivering COVID-19 treatments to the world's population. With healthcare spending on the rise, Thermo Fisher is expanding its services in a bid to capture even more of the market. To help address this need, The White House released a Pandemic Preparedness Plan and hopes to increase biodefense spending.
Thermo Fisher Scientific (TMO) closed the most recent trading day at $543.28, moving +1.37% from the previous trading session.
Thermo Fisher Scientific (TMO) closed at $544.81 in the latest trading session, marking a +0.78% move from the prior day.